A closer look at the credentials of CEO Dr David Atkins’s and Non-Executive Director Gavin Fox-Smith is also important when determine the value of this company.
Atkins was 22 years in senior roles with Johnson and Johnson, UK and US based.
Fox- Smith was 22 years in senior roles with Johnson and Johnson Medical Devices Australia/NZ. He is currently Non-Executive Director of Bowel Cancer Australia.
They are both older experienced leaders, with vast professional credentials, and just about as well connected as possible!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
-0.005(3.70%) |
Mkt cap ! $36.93M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 15.0¢ | 13.0¢ | $307.0K | 2.202M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 200000 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 7090 | 1 |
View Market Depth
| Last trade - 10.46am 07/08/2025 (20 minute delay) ? |
| RHY (ASX) Chart |